• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏和输尿管的尿路上皮肿瘤。一项流行病学、病理学及临床综述。

Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review.

作者信息

Genega Elizabeth M, Porter Christopher R

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA, USA.

出版信息

Am J Clin Pathol. 2002 Jun;117 Suppl:S36-48. doi: 10.1309/CCTJ-MKK1-XU0T-X3DY.

DOI:10.1309/CCTJ-MKK1-XU0T-X3DY
PMID:14569801
Abstract

Urothelial neoplasms occur with varying frequency at different sites along the urothelial tract. Approximately 5% of urothelial neoplasms occur in the kidneys and ureters, while the majority of these tumors occur in the urinary bladder. Consequently, urothelial disease of the bladder has been evaluated to a greater extent than urothelial tumors elsewhere, and many of the features of bladder urothelial neoplasms have been applied to these tumors at other sites. While the classification of urothelial neoplasms is the same for tumors in the bladder, kidney, and ureter, there are some features of urothelial neoplasms of the kidney and ureter that are unique to these sites. An epidemiologic, pathologic, and clinical review of urothelial neoplasms of the kidney and ureter is presented.

摘要

尿路上皮肿瘤在尿路的不同部位发生频率各异。约5%的尿路上皮肿瘤发生在肾脏和输尿管,而这些肿瘤的大多数发生在膀胱。因此,膀胱尿路上皮疾病的评估程度比其他部位的尿路上皮肿瘤更高,膀胱尿路上皮肿瘤的许多特征也被应用于其他部位的这些肿瘤。虽然膀胱、肾脏和输尿管肿瘤的尿路上皮肿瘤分类相同,但肾脏和输尿管尿路上皮肿瘤有一些该部位独有的特征。本文对肾脏和输尿管尿路上皮肿瘤进行了流行病学、病理学和临床综述。

相似文献

1
Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review.肾脏和输尿管的尿路上皮肿瘤。一项流行病学、病理学及临床综述。
Am J Clin Pathol. 2002 Jun;117 Suppl:S36-48. doi: 10.1309/CCTJ-MKK1-XU0T-X3DY.
2
Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.上尿路肿瘤:一项综述,重点关注肾盂肾盏系统的尿路上皮癌及其诊断和报告相关方面。
Adv Anat Pathol. 2008 May;15(3):127-39. doi: 10.1097/PAP.0b013e31817145a9.
3
A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs.一种新的建议,旨在对预先确定治疗方案的上尿路尿路上皮癌(UTUC)进行风险分层:低风险与高风险 UTUC。
Eur Urol. 2014 Aug;66(2):181-3. doi: 10.1016/j.eururo.2013.12.007. Epub 2013 Dec 17.
4
[European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].[欧洲上尿路尿路上皮癌诊断和治疗指南:2011年更新版。欧洲泌尿外科学会上尿路尿路上皮癌指南小组]
Actas Urol Esp. 2012 Jan;36(1):2-14. doi: 10.1016/j.acuro.2011.09.001. Epub 2011 Oct 29.
5
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌的全面基因组特征分析。
Eur Urol. 2017 Oct;72(4):641-649. doi: 10.1016/j.eururo.2017.05.048. Epub 2017 Jun 7.
6
Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.多模式治疗对转移性上尿路尿路上皮癌患者预后的影响:日本泌尿外科学会多机构全国病例系列研究的亚分析
Int J Urol. 2016 Mar;23(3):224-30. doi: 10.1111/iju.13031. Epub 2015 Dec 14.
7
[Upper urinary tract tumors pathology (ureter, pelvis and renal calyces)].[上尿路肿瘤病理学(输尿管、肾盂和肾盏)]
Arch Esp Urol. 2004 Apr;57(3):241-50.
8
Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.肾盂、输尿管和膀胱癌的癌具有致癌灶,这在肿瘤登记数据的流行病学分析中得到揭示。
Clin Genitourin Cancer. 2019 Dec;17(6):436-442. doi: 10.1016/j.clgc.2019.07.011. Epub 2019 Jul 19.
9
Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.上尿路尿路上皮癌:WHO/ISUP 1998共识分类与WHO 1999分类系统的比较
Urology. 2005 Aug;66(2):274-8. doi: 10.1016/j.urology.2005.03.011.
10
Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.肾盂和输尿管鳞状细胞癌:发病率、症状、治疗及预后
J Urol. 2007 Jul;178(1):51-6. doi: 10.1016/j.juro.2007.03.033. Epub 2007 May 11.

引用本文的文献

1
Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.肾输尿管切除术治疗上尿路上皮癌后局部复发的模式和危险因素。
World J Surg Oncol. 2020 May 30;18(1):114. doi: 10.1186/s12957-020-01877-w.
2
Leptomeningeal carcinomatosis as primary presentation of metastatic urothelial cancer.柔脑膜癌病作为转移性尿路上皮癌的主要表现
BMJ Case Rep. 2018 Nov 8;2018:bcr-2017-224150. doi: 10.1136/bcr-2017-224150.
3
Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
术前血清乳酸脱氢酶对预测上尿路上皮癌患者结局是否有用?
Cancer Med. 2018 Oct;7(10):5096-5106. doi: 10.1002/cam4.1751. Epub 2018 Aug 27.
4
Comparison of Radical Nephroureterectomy and Partial Ureterectomy for the Treatment of Upper Tract Urothelial Carcinoma.根治性肾输尿管切除术与部分输尿管切除术治疗上尿路尿路上皮癌的比较。
Biomed Res Int. 2018 Apr 26;2018:2793172. doi: 10.1155/2018/2793172. eCollection 2018.
5
Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report.立体定向体部放射治疗用于医学上无法手术、临床局限性肾盂尿路上皮癌:一例报告
Adv Radiat Oncol. 2017 Aug 30;3(1):57-61. doi: 10.1016/j.adro.2017.08.012. eCollection 2018 Jan-Mar.
6
Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria.评估无症状镜下血尿的常见诊断方法的成本效益
JAMA Intern Med. 2017 Jun 1;177(6):800-807. doi: 10.1001/jamainternmed.2017.0739.
7
Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.转移性上尿路尿路上皮癌与膀胱尿路上皮癌的临床病理特征比较。
Int Urol Nephrol. 2016 Apr;48(4):481-7. doi: 10.1007/s11255-016-1214-2. Epub 2016 Jan 21.
8
Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.放疗可能改善肾盂或输尿管 T3/T4 移行细胞癌患者的总生存率,并延缓膀胱癌复发。
BMC Cancer. 2011 Jul 14;11:297. doi: 10.1186/1471-2407-11-297.
9
Treatment of metastatic renal cell carcinoma and renal pelvic cancer.转移性肾细胞癌和肾盂癌的治疗。
Clin Exp Nephrol. 2011 Jun;15(3):331-338. doi: 10.1007/s10157-011-0438-9. Epub 2011 Apr 12.
10
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.同时性原位癌作为上尿路上皮癌复发和生存的独立预后参数:772 例患者的多中心分析。
World J Urol. 2011 Aug;29(4):487-94. doi: 10.1007/s00345-011-0645-8. Epub 2011 Jan 20.